HPI for Prevention of Hypotension During Cardiac Surgery

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorMackay Memorial Hospital

About this trial

Hypotension prediction index (HPI) was applied in various types of non-cardiac surgery with convincing benefits of preventing hypotensive events and clinical sequelae. Although HPI was validated in cardiac surgery, its clinical benefits are not proven yet. We aim to evaluate its effects on intraoperative hypotension and postoperative adverse events in cardiac surgery. In this randomized, single-blind trial, we will enroll adults scheduled for elective primary cardiac surgery under general anesthesia. Participants will be randomly assigned to intraoperative HPI-guided or non-HPI-guided hemodynamic management. The primary endpoint is the time-weighted average intraoperative hypotension below a mean arterial pressure threshold of 65 mmHg. The secondary endpoints are postoperative complications.

Eligibility criteria

Qualifiers

adult

elective, primary, isolated coronary arterial bypass surgery (CABG) or isolated valve surgery

provide inform consent.

Disqualifiers

arrhythmia (e.g., atrial fibrillation, atrial flutter)

intracardiac shunts

preoperative inotropic usage

preoperative supportive devices usage (e.g., intra-aortic balloon pump, extracorporeal membrane oxygenation, left ventricular assist device, or right ventricular assist device)

Trial design

Treatments tested in this trial

  • Hypotension prediction index (HPI)

Treatment groups

110 Participants
are divided into 2 treatment groups

Sponsors and collaborators